Haemophilus influenzae type b conjugate vaccine for preventing pneumonia in infants hospitalized for bronchiolitis: A case-control study

Academic Article

Abstract

  • Background: Haemophilus influenzae type b (Hib) conjugate vaccine reduces the risk of pneumonia in infants. Objective: To determine the effect of Hib conjugate vaccine (HibCV) on the prevention of pneumonia as a complication among infants hospitalized for bronchiolitis. Methods: This record-based case-control study was conducted at The Children's Hospital "Dr. Ovidio Aliaga U" in La Paz, Bolivia during 2003 and 2004. Cases were infants hospitalized for bronchiolitis under 1 year of age who developed radiological pneumonia during hospitalization. Controls were patients who had good clinical progress without the use of antibiotics. Pneumonia was defined by alveolar consolidation on chest X-ray that justified the use of antibiotics. Results: Eighty patients were studied (16 cases and 64 controls). Their median age was 4.5 months. Demographic and clinical features were similar in both groups, except for a higher proportion of vomiting (56.3% vs. 28.1%; p < 0.05) in the case group. The percentage of unvaccinated infants was significantly higher in cases (68.8% vs. 26.6%; p < 0.05) and the length of hospital stay longer (8.5 ± 5.4 vs. 3.1 ± 2.2 days; p < 0.05). There was a strong association between unvaccinated infants and the occurrence of pneumonia as a complication (odds ratio 6.1, 95% confidence interval 1.8-20.1; p < 0.01). Conclusions: Unvaccinated infants admitted for bronchiolitis have a higher risk of radiologically confirmed pneumonia. Larger studies are needed to validate these results and reconsider the burden of Hib infection among infants in less developed countries. Crown Copyright © 2009.
  • Authors

    Digital Object Identifier (doi)

    Author List

  • Salas AA; Salazar HJ; Velasco VH
  • Volume

  • 14
  • Issue

  • 1